26 May 2021
Testosterone treatment in men with obesity and type 2 diabetes may decrease their risk of developing non-alcoholic fatty liver disease, according to a study presented at the recent European Congress of Endocrinology.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024